Comparison of Remogliflozin and Canagliflozin as Add-On Therapy in Indian Uncontrolled T2DM Subject

被引：0

|

作者：

Shankar, Anand

机构：

来源：

DIABETES | 2020年 / 69卷

关键词：

D O I：

10.2337/db20-1114-P

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1114-P

引用

收藏

页数：2

相关论文

共 50 条

[41] Empagliflozin (EMPA) for ≥76 Weeks as Add-on to Metformin Plus Sulfonylurea (SU) in Patients with Type 2 Diabetes (T2DM)
Haering, Hans-Ulrich
Merker, Ludwig
Vedel, Anita
Roux, Christiansen Flavien
Salsali, Afshin
Kim, Gabriel
Meinicke, Thomas
Woerle, Hans J.
Broedl, Uli C.
DIABETES, 2014, 63 : A280 - A280
[42] Antihelminthic drug for T2DM therapy?
Joana Osório
Nature Reviews Endocrinology, 2014, 10 (12) : 702 - 702
[43] Long-Term Efficacy of Dapagliflozin as Add-On to Metformin (MET) in T2DM Inadequately Controlled with MET Alone
Bailey, Clifford J.
Gross, Jorge L.
Yadav, Manoj
Iqbal, Nayyar
Mansfield, Traci A.
List, James F.
DIABETES, 2011, 60 : A271 - A271
[44] Designing a new therapy for T2DM
Claire Greenhill
Nature Reviews Endocrinology, 2019, 15 : 684 - 684
[45] Time To Add-On Medication Use for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
Qiu, Ying
Fu, Alex Z.
Radican, Larry
DIABETES, 2010, 59 : A70 - +
[46] TIME TO ADD-ON MEDICATION USE FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) WHO FAILED METFORMIN MONOTHERAPY
Qiu, Y.
Fu, A. Z.
Radican, L.
VALUE IN HEALTH, 2010, 13 (07) : A299 - A299
[47] Effect of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) on Lipid Particles in Type 2 Diabetes Mellitus (T2DM)
Jones, Michael R.
Ford, Daniel M.
Baz-Hecht, Merav
Tao, Ben
Truitt, Kenneth E.
Chou, Hubert S.
DIABETES, 2013, 62 : A302 - A302
[48] Empagliflozin (EMPA) Compared with Glimepiride (GLIM) as Add-on to Metformin (MET) for 2 Years in Patients with Type 2 Diabetes (T2DM)
Ridderstrale, Martin
Andersen, Knut Robert
Zeller, Cordula
Kim, Gabriel
Woerle, Hans J.
Broedl, Uli C.
DIABETES, 2014, 63 : A70 - A70
[49] The Effect of Combination Therapy of Degludec and Liraglutide in Hospitalized Patients with Uncontrolled Type 2 Diabetes (T2DM)
Akiyama, Tomoaki
Yamada, Masayo
Katsuragawa, Sho
Terui, Sakiko
Minami, Taichi
Terauchi, Yasuo
DIABETES, 2017, 66 : A295 - A295
[50] DIABETES Add-on to metformin in T2DM-linagliptin or glimepiride?
Christensen, Mikkel
Knop, Filip K.
NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (10) : 576 - 578

← 1 2 3 4 5 →